inner-banner-bg

Advances in Hematology and Oncology Research(AHOR)

ISSN: 2692-5516 | DOI: 10.33140/AHOR

Impact Factor: 1.2

Potentiation of Efficacy of Chimeric Antigen Receptor (CAR) T-cell Therapy in Hematological Malignancies using FDA-Approved Small Molecule Sensitizing Agents

Citation

Anthony Morales, Ali R Jazirehi

Anthony Morales, Ali R Jazirehi (2022) Potentiation of Efficacy of CAR T-Cell Therapy in Hematological Malignancies using FDA-Approved Small Molecule Sensitizing Agents. Adv Hema Onco Res, 5(1): 84-88.

Abstract PDF